July 17, 2014in Blogs, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized2by Editor2005 Apotex Successfully Invalidates Patent on Nexium AstraZeneca has been selling Nexium in Canada for 13 years. It is prescribed to treat ulcers, gastroesophageal reflux disease (GERD) and related diseases. The active ingredient in Nexium is esomeprazole,…
